| Literature DB >> 30811460 |
Gavin Williams1,2, Linda Denehy3.
Abstract
A large body of evidence demonstrates that resistance training has been ineffective for improving walking outcomes in adults with neurological conditions. However, evidence suggests that previous studies have not aligned resistance exercise prescription to muscle function when walking. The main aim of this study was to determine whether a training seminar for clinicians could improve knowledge of gait and align resistance exercise prescription to the biomechanics of gait and muscle function for walking. A training seminar was conducted at 12 rehabilitation facilities with 178 clinicians. Current practice, knowledge and barriers to exercise were assessed by observation and questionnaire prior to and immediately after the seminar, and at three-month follow-up. Additionally, post-seminar support and mentoring was randomly provided to half of the rehabilitation facilities using a cluster randomised controlled trial (RCT) design. The seminar led to significant improvements in clinician knowledge of the biomechanics of gait and resistance training, the amount of ballistic (t = -2.38; p = .04) and conventional (t = -2.30; p = .04) resistance training being prescribed. However, ongoing post-seminar support and mentoring was not associated with any additional benefits F(1, 9) = .05, p = .83, partial eta squared = .01. Further, improved exercise prescription occurred in the absence of any change to perceived barriers. The training seminar led to significant improvements in the time spent in ballistic and conventional resistance training. There was no further benefit obtained from the additional post-seminar support. The seminar led to improved knowledge and significantly greater time spent prescribing task-specific resistance exercises.Entities:
Mesh:
Year: 2019 PMID: 30811460 PMCID: PMC6392279 DOI: 10.1371/journal.pone.0212168
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Study flow diagram.
Number of therapist questionnaires and patient observation sessions completed.
| Questionnaire timepoint | % | Observation session | ||||
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 1 | 2 | ||
| 178 | 170 | 136 | 80.0 | 68 | 81 | |
| 60 | 60 | 46 | 79.9 | 17 | 26 | |
| 56 | 53 | 42 | 80.7 | 26 | 25 | |
| 62 | 57 | 48 | 87.3 | 25 | 30 | |
aindicates the proportion of those who having completed questionnaire 2, also completed questionnaire 3.
Clinician self-reported confidence in their knowledge prior to and after the seminar.
| Timepoint 1 | Timepoint 2 | |||
|---|---|---|---|---|
| Strongly agree | Agree | Strongly agree | Agree | |
| Biomechanics of walking | 6.2% | 59.3% | 47.1% | 52.9% |
| Muscle function during walking | 5.9% | 52.0% | 52.9% | 46.5% |
| Impact of the UMNS | 6.8% | 56.5% | 28.8% | 64.1% |
| Principles of resistance training | 6.8% | 63.8% | 55.3% | 43.5% |
a p < .001 (Wilcoxon Signed Rank Test)
UMNS: Upper Motor Neurone Syndrome
Number and proportion of correct responses to the biomechanics of gait and principles of resistance training questions.
| Question | Timepoint 1 | Timepoint 2 | Timepoint 3 | ||
|---|---|---|---|---|---|
| Three most important muscle groups for forward propulsion when walking | 35 (20.2) | 151 (88.8) | 0.51 | 96 (70.6) | 0.39 |
| Primary role of the quadriceps | 71 (41.0) | 140 (82.3) | 91 (66.9) | ||
| Primary role of the hamstrings | 91 (52.6) | 118 (69.4) | 0.22 | 99 (72.8) | |
| Active phase of the hip extensors | 25 (14.5) | 121 (71.2) | 71 (52.2) | ||
| Active phase of the ankle plantarflexors | 127 (75.1) | 150 (88.2) | 121 (89.0) | ||
| Main strategy to increase walking speed | 36 (21.1) | 135 (79.4) | 69 (50.7) | ||
| Contribution of the ankle joint to overall leg power generation | 59 (34.3) | 124 (72.9) | 78 (57.4) | 0.27 | |
| Contribution of the Achilles tendon to ankle power generation | 14 (8.2) | 136 (80.0) | 79 (58.1) | ||
| Ipsilateral compensation strategy | 12 (7.2) | 40 (23.5) | 0.14 | 20 (14.7) | |
| Roles of the five main muscle groups | 27 (16.2) | 97 (57.1) | 0.35 | 55 (40.4) | 0.22 |
| ACSM guidelines for specificity | 76 (46.6) | 108 (63.5) | 71 (52.2) | ||
| Main strategies resistance training progression | 52 (31.7) | 89 (52.4) | 72 (52.9) | ||
| Power is measured as rate of force production | 67 (41.4) | 117 (86.0) | 93 (68.4) | ||
ES = effect size. Effect sizes reported for Chi-squared test are the phi coefficient.
a Significant difference (p < .01) compared to Timepoint 1 on a Wilcoxon Signed Rank Test
b Significant difference (p < .01) compared to Timepoint 1 on a Chi-squared test for independence
Clinician reported barriers and enablers (number and proportion).
| Timepoint 1 | Timepoint 2 | |
|---|---|---|
| Barriers | ||
| Patient capacity | 113 (63.8) | 96 (70.6) |
| Therapist confidence | 91 (51.4) | 53 (39.0) |
| Equipment | 89 (50.3) | 71 (52.2) |
| Enablers | ||
| Knowledge of biomechanics | 99 (72.8) | |
| Physical impairments | 96 (70.6) | |
| Improved confidence | 83 (61.0) | |
| Resistance training principles | 64 (47.1) | |
| Importance of ballistic training | 51 (37.5) |